Seelos Therapeutics Inc (SEEL)

[Dimitrios George]

Kleanthis was clearly voted out by a minority of shareholders and as such was forced to resign.

The company chose to not accept that resignation slapping a minority of the shareholders in the face. (If I may paraphrase you, BWAHAHAHAHA.)

Kleanthis has been a net seller of our stock while our new board members, management, and new employees have been putting their own money in via open market buys. However, Keanthis still owns more shares than any of the current management (Ed Cox owned more). And as your buddy Bicster points out, all those sells were good trades.

Kleanthis is an IMO an impediment to our success not an asset. And I will add that as the next opportunity to vote him out nears I for one will be very vocal in the need for the completion of the great change we have seen by removing this last problem.

Well, you have in NO way made the argument that Kleanthis is an impediment, only that he lost the vote because he sold some shares through an automatic program. Do you really think that Pascoe would have been allowed to do what he has done (staff and acquisition) without Kleanthis' personal stamp of approval? Kleanthis is not only the CEO of a biotech that is doing rather well these days but his scientific achievements and reputation arguably are much greater than the cumulative achievements of Apricus staff and management, past and present.